皮肤T细胞淋巴瘤-话题@MedSci

#皮肤T细胞淋巴瘤#

13篇内容 | 872人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2118768, encodeId=6ae92118e68c0, content=<a href='/topic/show?id=9c55e1986b9' target=_blank style='color:#2F92EE;'>#皮肤T细胞淋巴瘤#</a>（CTCLs）构成了一组皮肤来源T细胞的<a href='/topic/show?id=170699e5621' target=_blank style='color:#2F92EE;'>#非霍奇金淋巴瘤#</a>（T-NHLs）。<a href='/topic/show?id=0de5290588c' target=_blank style='color:#2F92EE;'>#免疫检查点抑制剂#</a>是治疗T细胞<a href='/topic/show?id=0fc31055368d' target=_blank style='color:#2F92EE;'>#T-NHLs#</a>的一种新兴疗法, objectTitle=JCI Insight：抗PD-1治疗后皮肤T细胞淋巴瘤过度进展的机制探究, objectType=article, longId=762439, objectId=810de6243904, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221120/1669013742685_4754896.webp, objectUrl=/article/show_article.do?id=810de6243904, replyNumber=0, likeNumber=87, createdTime=2023-03-11, rootId=0, userName=showtest, userId=8f0715, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=810de6243904, moduleTitle=JCI Insight：抗PD-1治疗后皮肤T细胞淋巴瘤过度进展的机制探究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=810de6243904)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1584238, encodeId=7bfc15842381f, content=<a href='/topic/show?id=9c55e1986b9' target=_blank style='color:#2F92EE;'>#皮肤T细胞淋巴瘤#</a>, objectTitle=JEADV：皮肤T细胞淋巴瘤的肠道菌群失调的特征研究, objectType=article, longId=724096, objectId=ba7be240966c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba7be240966c, replyNumber=0, likeNumber=48, createdTime=2022-04-13, rootId=0, userName=12498f17m71暂无昵称, userId=b8c717034263, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba7be240966c, moduleTitle=JEADV：皮肤T细胞淋巴瘤的肠道菌群失调的特征研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba7be240966c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1584237, encodeId=571d158423e1d, content=<a href='/topic/show?id=9c55e1986b9' target=_blank style='color:#2F92EE;'>#皮肤T细胞淋巴瘤#</a>, objectTitle=协和麒麟mogamulizumab单抗在中国递交上市申请，用于皮肤T细胞淋巴瘤, objectType=article, longId=213745, objectId=e743213e45ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e743213e45ef, replyNumber=0, likeNumber=37, createdTime=2021-07-06, rootId=0, userName=12498f17m71暂无昵称, userId=b8c717034263, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e743213e45ef, moduleTitle=协和麒麟mogamulizumab单抗在中国递交上市申请，用于皮肤T细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e743213e45ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1584236, encodeId=607f158423613, content=<a href='/topic/show?id=9c55e1986b9' target=_blank style='color:#2F92EE;'>#皮肤T细胞淋巴瘤#</a>, objectTitle=多细胞因子抑制剂BNZ-1治疗皮肤T细胞淋巴瘤：安全性和有效性良好, objectType=article, longId=197837, objectId=879319e8373b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=879319e8373b, replyNumber=0, likeNumber=44, createdTime=2020-07-22, rootId=0, userName=12498f17m71暂无昵称, userId=b8c717034263, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=879319e8373b, moduleTitle=多细胞因子抑制剂BNZ-1治疗皮肤T细胞淋巴瘤：安全性和有效性良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=879319e8373b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1584235, encodeId=2a831584235ea, content=<a href='/topic/show?id=9c55e1986b9' target=_blank style='color:#2F92EE;'>#皮肤T细胞淋巴瘤#</a>, objectTitle=Blood：晚期皮肤T细胞淋巴瘤STAT-6调控基因的全基因转录组分析, objectType=article, longId=194670, objectId=14c31946e072, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=14c31946e072, replyNumber=0, likeNumber=45, createdTime=2020-05-25, rootId=0, userName=12498f17m71暂无昵称, userId=b8c717034263, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=14c31946e072, moduleTitle=Blood：晚期皮肤T细胞淋巴瘤STAT-6调控基因的全基因转录组分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=14c31946e072)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1584234, encodeId=6c8c1584234de, content=<a href='/topic/show?id=9c55e1986b9' target=_blank style='color:#2F92EE;'>#皮肤T细胞淋巴瘤#</a>, objectTitle=Blood：皮肤T细胞淋巴瘤：循环肿瘤细胞的皮肤定植, objectType=article, longId=179595, objectId=25831e9595b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25831e9595b7, replyNumber=0, likeNumber=37, createdTime=2019-09-18, rootId=0, userName=12498f17m71暂无昵称, userId=b8c717034263, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25831e9595b7, moduleTitle=Blood：皮肤T细胞淋巴瘤：循环肿瘤细胞的皮肤定植, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25831e9595b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1584233, encodeId=eb661584233b8, content=<a href='/topic/show?id=9c55e1986b9' target=_blank style='color:#2F92EE;'>#皮肤T细胞淋巴瘤#</a>, objectTitle=Blood：抗生素可抑制皮肤T细胞淋巴瘤的活性, objectType=article, longId=176100, objectId=f54e1e610048, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f54e1e610048, replyNumber=0, likeNumber=38, createdTime=2019-07-25, rootId=0, userName=12498f17m71暂无昵称, userId=b8c717034263, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f54e1e610048, moduleTitle=Blood：抗生素可抑制皮肤T细胞淋巴瘤的活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f54e1e610048)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1584232, encodeId=174e158423270, content=<a href='/topic/show?id=9c55e1986b9' target=_blank style='color:#2F92EE;'>#皮肤T细胞淋巴瘤#</a>, objectTitle=Blood：抗生素抑制皮肤T细胞淋巴瘤患者肿瘤和疾病活动, objectType=article, longId=176080, objectId=0dd41e60808f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0dd41e60808f, replyNumber=0, likeNumber=43, createdTime=2019-07-25, rootId=0, userName=12498f17m71暂无昵称, userId=b8c717034263, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0dd41e60808f, moduleTitle=Blood：抗生素抑制皮肤T细胞淋巴瘤患者肿瘤和疾病活动, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0dd41e60808f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1584231, encodeId=f1261584231a9, content=<a href='/topic/show?id=9c55e1986b9' target=_blank style='color:#2F92EE;'>#皮肤T细胞淋巴瘤#</a>, objectTitle=Blood：GATA6过表达可诱导CD137配体异常表达，进而促进皮肤T细胞淋巴瘤进展, objectType=article, longId=148521, objectId=7ce6148521ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ce6148521ff, replyNumber=0, likeNumber=35, createdTime=2018-09-11, rootId=0, userName=12498f17m71暂无昵称, userId=b8c717034263, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ce6148521ff, moduleTitle=Blood：GATA6过表达可诱导CD137配体异常表达，进而促进皮肤T细胞淋巴瘤进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ce6148521ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1584230, encodeId=8e7915842301c, content=<a href='/topic/show?id=9c55e1986b9' target=_blank style='color:#2F92EE;'>#皮肤T细胞淋巴瘤#</a>, objectTitle=柳叶刀公布了Kyowa Kirin公司CCR4单抗Poteligeo 治疗皮肤T细胞淋巴瘤的III期临床数据, objectType=article, longId=146735, objectId=31ee146e35d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31ee146e35d9, replyNumber=0, likeNumber=42, createdTime=2018-08-17, rootId=0, userName=12498f17m71暂无昵称, userId=b8c717034263, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31ee146e35d9, moduleTitle=柳叶刀公布了Kyowa Kirin公司CCR4单抗Poteligeo 治疗皮肤T细胞淋巴瘤的III期临床数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=31ee146e35d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1584229, encodeId=f57615842297a, content=<a href='/topic/show?id=9c55e1986b9' target=_blank style='color:#2F92EE;'>#皮肤T细胞淋巴瘤#</a>, objectTitle=【2017 ASH】Brentuximab Vedotin对CD30+皮肤T细胞淋巴瘤的治疗效果显著优于甲氨蝶呤或贝沙罗汀标准方案, objectType=article, longId=123207, objectId=4dfc12320e42, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4dfc12320e42, replyNumber=0, likeNumber=40, createdTime=2017-12-14, rootId=0, userName=12498f17m71暂无昵称, userId=b8c717034263, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4dfc12320e42, moduleTitle=【2017 ASH】Brentuximab Vedotin对CD30+皮肤T细胞淋巴瘤的治疗效果显著优于甲氨蝶呤或贝沙罗汀标准方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4dfc12320e42)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1584228, encodeId=d5741584228c5, content=<a href='/topic/show?id=9c55e1986b9' target=_blank style='color:#2F92EE;'>#皮肤T细胞淋巴瘤#</a>, objectTitle=3期 ALCANZA临床试验表明Adcetris 可更好的改善皮肤T细胞淋巴瘤的治疗效果, objectType=article, longId=74414, objectId=5b78e4414c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b78e4414c7, replyNumber=0, likeNumber=38, createdTime=2016-08-05, rootId=0, userName=12498f17m71暂无昵称, userId=b8c717034263, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b78e4414c7, moduleTitle=3期 ALCANZA临床试验表明Adcetris 可更好的改善皮肤T细胞淋巴瘤的治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b78e4414c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1584227, encodeId=cd1a158422e8f, content=<a href='/topic/show?id=9c55e1986b9' target=_blank style='color:#2F92EE;'>#皮肤T细胞淋巴瘤#</a>, objectTitle=JCO：BV能有效治疗两种皮肤T细胞淋巴瘤, objectType=article, longId=53738, objectId=be7453e38d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=be7453e38d2, replyNumber=0, likeNumber=34, createdTime=2015-07-28, rootId=0, userName=12498f17m71暂无昵称, userId=b8c717034263, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be7453e38d2, moduleTitle=JCO：BV能有效治疗两种皮肤T细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be7453e38d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

皮肤T细胞淋巴瘤

2020-05-29

showtest (审核中...)

前往app查看评论内容

#皮肤T细胞淋巴瘤#（CTCLs）构成了一组皮肤来源T细胞的#非霍奇金淋巴瘤#（T-NHLs）。#免疫检查点抑制剂#是治疗T细胞#T-NHLs#的一种新兴疗法

JCI Insight：抗PD-1治疗后皮肤T细胞淋巴瘤过度进展的机制探究

2023-03-11发表于上海

12498f17m71暂无昵称 (审核中...)

前往app查看评论内容

#皮肤T细胞淋巴瘤#

JEADV：皮肤T细胞淋巴瘤的肠道菌群失调的特征研究

2022-04-13

12498f17m71暂无昵称 (审核中...)

前往app查看评论内容

#皮肤T细胞淋巴瘤#

协和麒麟mogamulizumab单抗在中国递交上市申请，用于皮肤T细胞淋巴瘤

2021-07-06

12498f17m71暂无昵称 (审核中...)

前往app查看评论内容

#皮肤T细胞淋巴瘤#

多细胞因子抑制剂BNZ-1治疗皮肤T细胞淋巴瘤：安全性和有效性良好

2020-07-22

12498f17m71暂无昵称 (审核中...)

前往app查看评论内容

#皮肤T细胞淋巴瘤#

Blood：晚期皮肤T细胞淋巴瘤STAT-6调控基因的全基因转录组分析

2020-05-25

12498f17m71暂无昵称 (审核中...)

前往app查看评论内容

#皮肤T细胞淋巴瘤#

Blood：皮肤T细胞淋巴瘤：循环肿瘤细胞的皮肤定植

2019-09-18

12498f17m71暂无昵称 (审核中...)

前往app查看评论内容

#皮肤T细胞淋巴瘤#

Blood：抗生素可抑制皮肤T细胞淋巴瘤的活性

2019-07-25

12498f17m71暂无昵称 (审核中...)

前往app查看评论内容

#皮肤T细胞淋巴瘤#

Blood：抗生素抑制皮肤T细胞淋巴瘤患者肿瘤和疾病活动

2019-07-25

12498f17m71暂无昵称 (审核中...)

前往app查看评论内容

#皮肤T细胞淋巴瘤#

Blood：GATA6过表达可诱导CD137配体异常表达，进而促进皮肤T细胞淋巴瘤进展

2018-09-11

12498f17m71暂无昵称 (审核中...)

前往app查看评论内容

#皮肤T细胞淋巴瘤#

柳叶刀公布了Kyowa Kirin公司CCR4单抗Poteligeo 治疗皮肤T细胞淋巴瘤的III期临床数据

2018-08-17

12498f17m71暂无昵称 (审核中...)

前往app查看评论内容

#皮肤T细胞淋巴瘤#

【2017 ASH】Brentuximab Vedotin对CD30+皮肤T细胞淋巴瘤的治疗效果显著优于甲氨蝶呤或贝沙罗汀标准方案

2017-12-14

12498f17m71暂无昵称 (审核中...)

前往app查看评论内容

#皮肤T细胞淋巴瘤#

3期 ALCANZA临床试验表明Adcetris 可更好的改善皮肤T细胞淋巴瘤的治疗效果

2016-08-05

12498f17m71暂无昵称 (审核中...)

前往app查看评论内容

#皮肤T细胞淋巴瘤#

JCO：BV能有效治疗两种皮肤T细胞淋巴瘤

2015-07-28

科室
- - 订阅+
  - 更多科室
工具
服务